• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Intuitive Surgical shares rise on expanded surgical robot quota in China

Intuitive Surgical shares rise on expanded surgical robot quota in China

October 31, 2018 By Fink Densford

Intuitive Surgical

Intuitive Surgical (NSDQ:ISRG) shares have risen over 5% in pre-market trading after the Chinese government released a new Large-Scale Medical Equipment Configuration Plan calling for an additional 154 surgical robot systems to be deployed in the country by the end of 2020.

The official release from the Chinese Government calls for a total of 197 endoscopic surgical instrument control systems, or surgical robots, by the end of 2020. That number includes an additional 154 new systems.

The last time the government issued a similar quota expansion was in 2013, according to a Leerink Partner letter to investors by analyst Richard Newitter.

After the last quota was issued in 2013, the majority of the systems weren’t sold until 2015, Newitter wrote, leading him to believe that a similar purchasing spread will occur with the current quota expansion. He expects that 10% of the 154 units will be acquired in 2018, 30% in 2019 and 60% in 2020.

Currently, Intuitive has more than 80 robotic platforms installed in civilian and military hospitals in the region, according to the letter. Newitter expects that the majority of the new quota, approximately 90%, will go to Intuitive.

“We expect ISRG will fulfill most, if not all, of the new quota but acknowledge that competitive offerings, over time and if available before 2020, might have a shot at winning some of the placement quota,” Newitter wrote in a letter to investors. “While we do not know the exact intentions of the Chinese government, we suspect that ISRG will place the lion’s share (~90%+) of additional systems under the new quota given Da Vinci’s capabilities vs. other systems.”

He went on to say that there is “some risk around quota fulfillment timing” depending on when other major offerings, like those from Johnson & Johnson (NYSE:JNJ), Medtronic (NYSE:MDT), TransEnterix (NYSE:TRXC) and Auris Health, hit the market.

Shares in Intuitive rose over 5% in pre-market trading, and have risen 4.5% in early morning trading, at $512.89 as of 9:36 a.m. EDT.

Earlier this month, shares of Intuitive Surgical (NSDQ:ISRG) got a pre-market bump after the robot-assisted surgery pioneer posted third-quarter results that beat the consensus forecast, despite lower profits, and upped its outlook on procedure growth for the year.

Filed Under: Business/Financial News, Featured, Surgical Robotics Tagged With: Intuitive Surgical

More recent news

  • EBR Systems raises $36.1M for leadless pacing tech
  • The biggest cardiovascular tech news out of EuroPCR 2025
  • CardiaWave has positive 12-month Valvosoft results
  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Medtronic has new Cardiovascular, CST leaders after longtime exec departs

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy